US 9198927
Targeting opposite strand replication intermediates of single-stranded viruses by RNAI
granted A61KA61K31/713A61P
Quick answer
US patent 9198927 (Targeting opposite strand replication intermediates of single-stranded viruses by RNAI) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/713, A61P, A61P31/12, A61P31/14